MX9200374A - Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. - Google Patents
Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene.Info
- Publication number
- MX9200374A MX9200374A MX9200374A MX9200374A MX9200374A MX 9200374 A MX9200374 A MX 9200374A MX 9200374 A MX9200374 A MX 9200374A MX 9200374 A MX9200374 A MX 9200374A MX 9200374 A MX9200374 A MX 9200374A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- procedure
- steroid esters
- new steroid
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9100342A SE9100342D0 (sv) | 1991-02-04 | 1991-02-04 | Novel steroid esters |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9200374A true MX9200374A (es) | 1992-08-01 |
Family
ID=20381807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9200374A MX9200374A (es) | 1991-02-04 | 1992-01-29 | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. |
Country Status (38)
Country | Link |
---|---|
US (1) | US5614514A (es) |
EP (1) | EP0572451B1 (es) |
JP (1) | JP2947933B2 (es) |
KR (1) | KR100205835B1 (es) |
CN (3) | CN1039329C (es) |
AP (1) | AP365A (es) |
AT (1) | ATE164589T1 (es) |
BG (1) | BG61816B1 (es) |
CA (1) | CA2100453A1 (es) |
CZ (1) | CZ282057B6 (es) |
DE (1) | DE69224982T2 (es) |
DK (1) | DK0572451T3 (es) |
DZ (1) | DZ1554A1 (es) |
EE (1) | EE03110B1 (es) |
ES (1) | ES2114931T3 (es) |
FI (1) | FI933451A (es) |
HK (1) | HK1004335A1 (es) |
HU (1) | HU221168B1 (es) |
IE (1) | IE920167A1 (es) |
IL (1) | IL100542A (es) |
IS (1) | IS1653B (es) |
MA (1) | MA22407A1 (es) |
MX (1) | MX9200374A (es) |
MY (1) | MY111502A (es) |
NO (1) | NO304074B1 (es) |
NZ (1) | NZ241211A (es) |
PL (1) | PL170383B1 (es) |
PT (1) | PT100087B (es) |
RO (1) | RO111272B1 (es) |
RU (1) | RU2112775C1 (es) |
SE (1) | SE9100342D0 (es) |
SK (1) | SK281802B6 (es) |
TN (1) | TNSN92008A1 (es) |
TW (1) | TW287166B (es) |
UA (1) | UA43825C2 (es) |
WO (1) | WO1992013873A1 (es) |
YU (1) | YU48893B (es) |
ZA (1) | ZA92234B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
BR9307746A (pt) * | 1993-01-08 | 1995-11-14 | Astra Ab | Derivados de esteróides especificos para otratamento de cólon e ileo |
US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US6372712B1 (en) | 1998-05-22 | 2002-04-16 | The Board Of Trustees Of The Leland Stanford Jr. University | Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand |
IL146132A0 (en) | 1999-05-27 | 2002-07-25 | Euro Celtique Sa | Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments |
US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
HRP20010018A2 (en) | 2001-01-09 | 2002-12-31 | Pliva D D | Novel anti-inflammatory compounds |
US20050009798A1 (en) | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
AU2003217535A1 (en) * | 2002-02-20 | 2003-09-09 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids |
CA2489402A1 (en) | 2002-07-08 | 2004-01-15 | Pliva-Istrazivacki Institut D.O.O. | New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
JP4530851B2 (ja) | 2002-07-08 | 2010-08-25 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | ステロイド/非ステロイド抗炎症活性分子、抗新生物活性分子および抗ウイルス活性分子用担体としての新規な化合物、組成物 |
US20040157810A1 (en) * | 2002-08-23 | 2004-08-12 | Teicher Martin H. | Corticosteroid conjugates and uses thereof |
WO2004033478A2 (en) * | 2002-10-08 | 2004-04-22 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
HRP20030324A2 (en) | 2003-04-24 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | Compounds of antiinflammatory effect |
HRP20030603A2 (en) | 2003-07-25 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Substituted furochromene compounds of antiinflammatory action |
HRP20030604A2 (en) | 2003-07-25 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | Substituted furochromenes, preparation thereof andtheir antiinflammatory action |
WO2005016352A1 (en) * | 2003-08-05 | 2005-02-24 | Sepracor Inc. | AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ß2 ADRENERGIC AGONISTS |
MX2007005073A (es) | 2004-10-27 | 2007-06-25 | Glaxosmithkline Zagreb | Conjugados con actividad antiinflamtoria. |
EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
US8737506B1 (en) | 2010-12-29 | 2014-05-27 | Sprint Communications Company L.P. | Determination of transmit diversity transmission delays |
US8437713B1 (en) | 2011-02-16 | 2013-05-07 | Sprint Communications Company L.P. | Wireless transmit diversity control by location of a wireless communication device |
US8565686B2 (en) | 2011-06-30 | 2013-10-22 | Sprint Communications Company L.P. | Power status multipath search window sizing for wireless communications |
TWI620578B (zh) | 2012-02-10 | 2018-04-11 | 台灣微脂體股份有限公司 | 用以減少眼用類固醇的倂發症之藥學組成物 |
JP5965187B2 (ja) * | 2012-03-30 | 2016-08-03 | 小林製薬株式会社 | 油性軟膏剤 |
CN109985048B (zh) * | 2017-12-29 | 2021-06-29 | 广州市赛普特医药科技股份有限公司 | 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126375A (en) * | 1964-03-24 | Chioacyl | ||
US3197469A (en) * | 1958-08-06 | 1965-07-27 | Pharmaceutical Res Products In | 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor |
US3048581A (en) * | 1960-04-25 | 1962-08-07 | Olin Mathieson | Acetals and ketals of 16, 17-dihydroxy steroids |
US3357974A (en) * | 1965-12-28 | 1967-12-12 | Merck & Co Inc | Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones |
US3758686A (en) * | 1971-12-07 | 1973-09-11 | American Cyanamid Co | Method of using steroid acetonides |
SE378109B (es) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
US3796701A (en) * | 1973-02-26 | 1974-03-12 | Squibb & Sons Inc | 5alpha,9-oxazino steroids and 9-carboxamido steroids |
SE8008524L (sv) * | 1980-12-04 | 1982-06-05 | Draco Ab | 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand |
US4304727A (en) * | 1980-12-05 | 1981-12-08 | The Upjohn Company | 9α-Debromination |
JPS58176485A (ja) * | 1982-04-08 | 1983-10-15 | Nippon Denso Co Ltd | 可変容量圧縮機 |
US4749649A (en) * | 1983-05-16 | 1988-06-07 | The Upjohn Company | Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen |
JPS6067496A (ja) * | 1983-09-26 | 1985-04-17 | Ota Seiyaku Kk | フルオシノロン16,17−アセトニド21−ブチレ−トおよびその製造法 |
IT1196142B (it) * | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
SE8403905D0 (sv) * | 1984-07-30 | 1984-07-30 | Draco Ab | Liposomes and steroid esters |
-
1991
- 1991-02-04 SE SE9100342A patent/SE9100342D0/xx unknown
- 1991-12-27 IL IL10054291A patent/IL100542A/xx not_active IP Right Cessation
- 1991-12-30 TW TW080110262A patent/TW287166B/zh active
-
1992
- 1992-01-06 NZ NZ241211A patent/NZ241211A/xx unknown
- 1992-01-13 ZA ZA92234A patent/ZA92234B/xx unknown
- 1992-01-21 IE IE016792A patent/IE920167A1/en not_active IP Right Cessation
- 1992-01-22 YU YU6492A patent/YU48893B/sh unknown
- 1992-01-22 DZ DZ920006A patent/DZ1554A1/fr active
- 1992-01-27 AP APAP/P/1992/000354A patent/AP365A/en active
- 1992-01-29 CA CA002100453A patent/CA2100453A1/en not_active Abandoned
- 1992-01-29 ES ES92904423T patent/ES2114931T3/es not_active Expired - Lifetime
- 1992-01-29 SK SK797-93A patent/SK281802B6/sk unknown
- 1992-01-29 PL PL92300351A patent/PL170383B1/pl unknown
- 1992-01-29 CZ CS931495A patent/CZ282057B6/cs not_active IP Right Cessation
- 1992-01-29 AT AT92904423T patent/ATE164589T1/de not_active IP Right Cessation
- 1992-01-29 KR KR1019930702299A patent/KR100205835B1/ko not_active IP Right Cessation
- 1992-01-29 DE DE69224982T patent/DE69224982T2/de not_active Expired - Fee Related
- 1992-01-29 JP JP4504217A patent/JP2947933B2/ja not_active Expired - Fee Related
- 1992-01-29 HU HU9302243A patent/HU221168B1/hu not_active IP Right Cessation
- 1992-01-29 RO RO93-01094A patent/RO111272B1/ro unknown
- 1992-01-29 WO PCT/SE1992/000056 patent/WO1992013873A1/en active IP Right Grant
- 1992-01-29 MX MX9200374A patent/MX9200374A/es unknown
- 1992-01-29 RU RU93053632A patent/RU2112775C1/ru active
- 1992-01-29 DK DK92904423T patent/DK0572451T3/da active
- 1992-01-29 UA UA93004296A patent/UA43825C2/uk unknown
- 1992-01-29 EP EP92904423A patent/EP0572451B1/en not_active Expired - Lifetime
- 1992-01-29 US US08/094,100 patent/US5614514A/en not_active Expired - Fee Related
- 1992-01-31 MY MYPI92000158A patent/MY111502A/en unknown
- 1992-02-03 PT PT100087A patent/PT100087B/pt not_active IP Right Cessation
- 1992-02-03 CN CN92100797A patent/CN1039329C/zh not_active Expired - Fee Related
- 1992-02-03 MA MA22693A patent/MA22407A1/fr unknown
- 1992-02-03 IS IS3809A patent/IS1653B/is unknown
- 1992-02-04 TN TNTNSN92008A patent/TNSN92008A1/fr unknown
-
1993
- 1993-08-02 NO NO932762A patent/NO304074B1/no not_active IP Right Cessation
- 1993-08-02 BG BG98011A patent/BG61816B1/bg unknown
- 1993-08-03 FI FI933451A patent/FI933451A/fi unknown
-
1994
- 1994-11-23 EE EE9400330A patent/EE03110B1/xx not_active IP Right Cessation
-
1996
- 1996-10-22 CN CN96122759A patent/CN1076607C/zh not_active Expired - Fee Related
- 1996-11-01 CN CN96114411A patent/CN1076606C/zh not_active Expired - Fee Related
-
1998
- 1998-04-24 HK HK98103446A patent/HK1004335A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
MX9200324A (es) | Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene. | |
MX9206503A (es) | Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene. | |
MX9202289A (es) | Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
MX9206938A (es) | Nuevos derivados peptidos, proceso para su preparacion y preparacion farmaceutica que comprende tales derivados. | |
MX9205280A (es) | Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9202619A (es) | Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene. | |
MX9204140A (es) | Nuevos derivados de analogos de taxol, procedimiento para su preparacion y composicion farmaceutica que los contienen. | |
MX9100317A (es) | Nuevos compuestos de beta-lactama,procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
MX9202982A (es) | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
MX9202748A (es) | Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene. | |
MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9102580A (es) | Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene. | |
MX9201058A (es) | Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene. | |
MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
MX9202300A (es) | Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9201848A (es) | Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen. | |
MX9204395A (es) | Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9102499A (es) | Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9207269A (es) | Bencimidazoles substituidos, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9201846A (es) | Polisacaridos sulfatados, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9200996A (es) | Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9204648A (es) | Nuevos derivados de esteres, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9204239A (es) | Quinolin-2-il-metoxibencilhindroxiureas, procedimiento para su preparacion y medicamentos que las contienen. |